Peter Hirth is a director of Vaxcyte Inc.
Person profile
Roles
Address
Foster City, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Aligos Therapeutics, Inc.
28 Feb 24
4
Aligos Therapeutics, Inc.
21 Jul 23
4
Vaxcyte, Inc.
15 Jun 23
4
IO Biotech, Inc.
13 Jun 23
4
Aligos Therapeutics, Inc.
27 Jun 22
4
Vaxcyte, Inc.
3 Jun 22
4
IO Biotech, Inc.
31 May 22
4
IO Biotech, Inc.
8 Nov 21
3
IO Biotech, Inc.
4 Nov 21
4
Aligos Therapeutics, Inc.
17 Jun 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Feb 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.96 | 4,411 | 4.23 k | 4,411 |
27 Feb 24 | ALGS Aligos Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 26.58 | 15,000 | 398.70 k | 0 |
20 Jul 23 | ALGS Aligos Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1 | 20,000 | 20.00 k | 20,000 |
13 Jun 23 | PCVX Vaxcyte | Common Stock | Grant | Acquire A | No | No | 0 | 2,500 | 0.00 | 5,625 |
13 Jun 23 | PCVX Vaxcyte | Stock Option Common Stock | Grant | Acquire A | No | No | 53.08 | 15,000 | 796.20 k | 15,000 |
8 Jun 23 | IOBT IO Biotech | Stock Option Common Stock | Grant | Acquire A | No | No | 2.075 | 41,533 | 86.18 k | 41,533 |